Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)
CompletedOBSERVATIONAL
Enrollment
1,320
Participants
Timeline
Start Date
July 14, 2014
Primary Completion Date
August 15, 2015
Study Completion Date
August 15, 2015
Conditions
Sepsis, Severe Sepsis and Septic Shock
Trial Locations (1)
43210
Wexner Medical Center at The Ohio State University, Columbus
All Listed Sponsors
lead
Ohio State University
OTHER
NCT02232750 - Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14) | Biotech Hunter | Biotech Hunter